Acer Therapeutics Inc ACER:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/24/22 EDT
1.22quote price arrow up+0.03 (+2.52%)
Volume
164,567
52 week range
1.16 - 3.77
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.22
  • 52 Week High3.77
  • 52 Week High Date04/04/22
  • 52 Week Low1.16
  • 52 Week Low Date06/23/22

Key Stats

  • Market Cap21.70M
  • Shares Out17.79M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change-46.49

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.22
  • 52 Week High3.77
  • 52 Week High Date04/04/22
  • 52 Week Low1.16
  • 52 Week Low Date06/23/22
  • Market Cap21.70M
  • Shares Out17.79M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change-46.49

RATIOS/PROFITABILITY

  • EPS (TTM)-1.39
  • P/E (TTM)-0.88
  • Fwd P/E (NTM)-0.47
  • EBITDA (TTM)-18.299M
  • ROE (TTM)-472.99%
  • Revenue (TTM)360,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,539.36%
  • Debt To Equity (MRQ)-130.03%

EVENTS

  • Earnings Date08/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acer Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Acer Therapeutics Inc. is a pharmaceutical company, which is focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. The Company’s pipeline includes four programs: ACER-001 (sodium phenylbutyrate), ACER-801 (osanetant), EDSIVO (celiprolol) and ACER-2820 (emetine). ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle...
Stephen Aselage
Independent Chairman of the Board
Christopher Schelling
President, Chief Executive Officer, Director
Tanya Hayden
Chief Operating Officer
Harry Palmin
Chief Financial Officer
Address
One Gateway Center (300 Washington St.)
Suite 356
Newton, MA
02458
United States

Top Peers

SYMBOLLASTCHG%CHG
IDRA
Idera Pharmaceuticals Inc
0.33-0.1261-27.6474%
RVPH
Reviva Pharmaceuticals Holdings, Inc.
1.15UNCHUNCH
APRE
Aprea Therapeutics Inc
0.8004-0.0345-4.1322%
GRAY
Graybug Vision Inc
0.8238-0.0202-2.3934%
TPST
Tempest Therapeutics Inc
2.41+0.10+4.33%